Skip to content
Menu

BioStem Technologies Q3 EPS $(0.64) Misses $(0.43) Estimate, Sales $7.641M Beat $7.167M Estimate

Benzinga Newsdesk 1 week ago

NewsEarningsEarnings BeatsEarnings Misses

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

BioStem Technologies (NASDAQ:BSEM) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.43) by 48.84 percent. This is a 2233.33 percent decrease over earnings of $0.03 per

BioStem Technologies (NASDAQ:BSEM) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.43) by 48.84 percent. This is a 2233.33 percent decrease over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $7.641 million which beat the analyst consensus estimate of $7.167 million by 6.61 percent. This is a 27.04 percent decrease over sales of $10.473 million the same period last year.

Read at benzinga.com